NIT
SAGE

NumerixS Investment Technologies’s Sage Therapeutics SAGE Stock Holding History

NumerixS Investment Technologies’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,400
Closed -$40K – 1268
2020
Q1 		$40K Buy
+1,400
New +$81.1K 0.02% 664
2018
Q4 		– Sell
-4,300
Closed -$594K – 1334
2018
Q3 		$594K Buy
+4,300
New +$664K 0.11% 256
2018
Q1 		– Sell
-800
Closed -$132K – 1249
2017
Q4 		$132K Buy
+800
New +$77.6K 0.03% 593
2017
Q2 		– Sell
-700
Closed -$50K – 1320
2017
Q1 		$50K Buy
+700
New +$41K 0.01% 1017

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

NumerixS Investment Technologies's SAGE Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Sage Therapeutics (SAGE) in Q2 2020, closing a stake of 1,400 shares — an estimated $40K sold.

NumerixS Investment Technologies first reported a position in SAGE in Q1 2017 and held it in 4 quarters. The position peaked at $594K in Q3 2018. 217 funds tracked by Wall St. Rank hold SAGE as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Sage Therapeutics position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,400 Sage Therapeutics shares in Q2 2020, an estimated $40K.
  • NumerixS Investment Technologies first reported a position in Sage Therapeutics in Q1 2017 and held it in 4 quarters.
  • NumerixS Investment Technologies's Sage Therapeutics position peaked at $594K in Q3 2018.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.